With low dose starting at 1,290 per month, analysts are expecting a two-fold jump in the sale of GLP-1 units over the next three months due to the steep price cuts.

Kansas House Speaker Dan Hawkins abruptly sent lawmakers home to block discussion on a drug pricing bill. What lawmakers are ...

Novartis, an innovative medicines company based in Basel, Switzerland, will continue to boost its multidimensional investment strategy in China, by expanding innovation, building manufacturing ...

Sen. Josh Hawley wants a slew of records from two abortion drug manufacturers, including those related to the safety of the ...

For STEM students considering career paths, the PA, NJ, & DE region is recognized as one of the leading biotechnology & ...

This reflects the confidence pharmaceutical innovators place in Pyramid’s expanded state-of-the-art facility to deliver ...

Deflationary “race‑to‑the‑bottom” competition drives many essential generics below sustainable cost, prompting market exits and reduced investment, particularly for low‑priced sterile injectables.

Mo., is launching investigations into two mifepristone manufacturers that he says profited off the abortion drug despite evidence that it "poses grave risks to women." Hawley notified the two ...

LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug ...

Updated terms call for ImmunityBio to initiate manufacturing at the Dunkirk plant by the end of 2028, at which point the company could purchase the property for $1.

The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...